VEGFR2 activity on myeloid cells mediates immune suppression in the tumor microenvironment
Yuqing Zhang(Cancer Genetics (United States)), Rolf A. Brekken(Southwestern Medical Center)
Cited by 51
Related Papers
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution
|JCI Insight|2019|281
Sitravatinib potentiates immune checkpoint blockade in refractory cancer models
|JCI Insight|2018|111
Phosphorylation of Akt and ERK1/2 Is Required for VEGF-A/VEGFR2-Induced Proliferation and Migration of Lymphatic Endothelium
|PLoS ONE|2011|99
Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer
|EMBO Molecular Medicine|2019|87